Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gaspar

Showing results (71-80 of 192) with videos related to

Pageof 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 28, 2014
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinibGregory N Gan, Andrew J Weickhardt, Benjamin Scheier, et al.
Journal of Neuro-Oncology|June 5, 2013
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomideKrishna Reddy, Laurie E Gaspar, Brian D Kavanagh, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 1999
Does race influence survival for esophageal cancer patients treated on the radiation and chemotherapy arm of RTOG #85-01?O E Streeter, K L Martz, L E Gaspar, et al.
American Journal of Clinical Oncology|August 10, 1999
Prognostic factors and survival in patients with spinal cord gliomas after radiation therapyM Abdel-Wahab, B Corn, A Wolfson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2008
Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomasAmanda L Schwer, Brian D Kavanagh, Robert McCammon, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomasEmma C Fields, Denise Damek, Laurie E Gaspar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology GroupLaurie E Gaspar, Kari Chansky, Kathy S Albain, et al.
Cancer|December 1, 1993
Primary cerebral fibrosarcomas. Clinicopathologic study and review of the literatureL E Gaspar, I R Mackenzie, J J Gilbert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 6, 2021
Assessment of extracranial metastatic disease in patients with brain metastases: How much effort is needed in the context of evolving survival prediction models?Carsten Nieder, Minesh P Mehta, Matthias Guckenberger, et al.
The British Journal of Dermatology|March 23, 2010
Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitroE A Langan, Y Ramot, A Hanning, et al.
Pageof 20

Showing results (71-80 of 192) with videos related to

Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|January 28, 2014
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinibGregory N Gan, Andrew J Weickhardt, Benjamin Scheier, et al.
Journal of Neuro-Oncology|June 5, 2013
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomideKrishna Reddy, Laurie E Gaspar, Brian D Kavanagh, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 1999
Does race influence survival for esophageal cancer patients treated on the radiation and chemotherapy arm of RTOG #85-01?O E Streeter, K L Martz, L E Gaspar, et al.
American Journal of Clinical Oncology|August 10, 1999
Prognostic factors and survival in patients with spinal cord gliomas after radiation therapyM Abdel-Wahab, B Corn, A Wolfson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2008
Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomasAmanda L Schwer, Brian D Kavanagh, Robert McCammon, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomasEmma C Fields, Denise Damek, Laurie E Gaspar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology GroupLaurie E Gaspar, Kari Chansky, Kathy S Albain, et al.
Cancer|December 1, 1993
Primary cerebral fibrosarcomas. Clinicopathologic study and review of the literatureL E Gaspar, I R Mackenzie, J J Gilbert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 6, 2021
Assessment of extracranial metastatic disease in patients with brain metastases: How much effort is needed in the context of evolving survival prediction models?Carsten Nieder, Minesh P Mehta, Matthias Guckenberger, et al.
The British Journal of Dermatology|March 23, 2010
Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitroE A Langan, Y Ramot, A Hanning, et al.
Pageof 20